22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
Affordable housing and infill developers can benefit from recently enacted housing laws and Brownfie...
Read More >
Q. Now that medical marijuana is legal in New Jersey, does the Law Against Discrimination require e...
Read More >
One hotly debated aspect of the Affordable Care Act (“ACA”) has been the so-called “Cadillac Tax”...
Read More >
There has been a drumbeat of news reports about Wuhan, China, a city more populous than any in the U...
Read More >
U.S. District Court Judge Kimberly Mueller just granted a preliminary injunction to block Assembly B...
Read More >
Q: An hourly employee has hit 40 hours at noon on Friday, can I send them home to avoid overtime? A...
Read More >